Soleo Health Appoints Jody Thompson as New Senior Vice President of Business Development, Rare Disease

Soleo Health Appoints Jody Thompson as New Senior Vice President of Business Development, Rare Disease GlobeNewswire December 08, 2025 FRISCO, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Jody Thompson to the role of senior vice president of […]

Nukik Corporation and Agnico Eagle Sign MOU to Advance Commercial Negotiations & Technical Collaboration on the Kivalliq Hydro-Fibre Link

Nukik Corporation and Agnico Eagle Sign MOU to Advance Commercial Negotiations & Technical Collaboration on the Kivalliq Hydro-Fibre Link Agnico Eagle partnership highlights the KHFL's role in replacing diesel generated electricity and supporting sustainable mining in Nunavut GlobeNewswire December 08, 2025 RANKIN INLET, Nunavut, Dec. 08, 2025 (GLOBE NEWSWIRE) — Nukik Corporation and Agnico Eagle

Digits Launches Ask Digits, a 24/7 AI Assistant for Real-Time Financial Answers and Actions

Digits Launches Ask Digits, a 24/7 AI Assistant for Real-Time Financial Answers and Actions GlobeNewswire December 08, 2025 SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Digits, the world's first Agentic General Ledger(TM) (AGL(R)), officially launched Ask Digits, a new AI-powered assistant that gives business owners and accountants a unified place to ask questions, take

Clip Money Inc. Announces Expanded Partnership with Centennial Delivering Cash Management Solutions to 1600+ Retailers

Clip Money Inc. Announces Expanded Partnership with Centennial Delivering Cash Management Solutions to 1600+ Retailers GlobeNewswire December 08, 2025 ATLANTA, Dec. 08, 2025 (GLOBE NEWSWIRE) — Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), operator of North America's only multi-bank cash deposit system for businesses with over 8,000 deposit accepting locations,

IBN Announces Latest Episode of The Stock2Me Podcast featuring CEO Greg Campbell and CFO Jeff Clayborne of Newton Golf Company Inc.

IBN Announces Latest Episode of The Stock2Me Podcast featuring CEO Greg Campbell and CFO Jeff Clayborne of Newton Golf Company Inc. GlobeNewswire December 08, 2025 AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the

SPX Technologies to Acquire Crawford United

SPX Technologies to Acquire Crawford United Expands SPX Technologies' HVAC Capabilities with Highly Engineered Custom Air-Handling Solutions GlobeNewswire December 08, 2025 CHARLOTTE, N.C. and CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) (“SPX” or the “Company”) and Crawford United Corporation (OTC: CRAWA) (“Crawford United”) announced today that they have entered into a

EBZT Announces Sports Edge AI Development for Polymarket Sports Prediction Markets

EBZT Announces Sports Edge AI Development for Polymarket Sports Prediction Markets Public OTC AI stock aims to give investors exposure to AI sports betting-style trading in the growing prediction markets space GlobeNewswire December 08, 2025 Jacksonville, Florida, Dec. 08, 2025 (GLOBE NEWSWIRE) — Everything Blockchain Inc. (OTC: EBZT) (“EBZT” or the “Company”), a public AI

Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs

Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs GlobeNewswire December 08, 2025 FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) patients now treated; first systemic

CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia

CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia GlobeNewswire December 08, 2025 SINGAPORE, Dec. 08, 2025 (GLOBE NEWSWIRE) — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical

Scroll to Top